HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.
Baruch Itzhak, Speaker at Diabetes Conferences
Keynote Presentation (Virtual)
Baruch Itzhak, Tel Aviv University, Israel

People with type 2 diabetes (T2DM) are recognized as having a 2–4 times increased risk of heart failure (HF). Ambulatory diabetes care has long concentrated on the prevention of microvascular and arterial disease, and surveillance for manageable problems such as with the fe [....] » Read More

Kensly Flecher, Speaker at Obesity Conferences
Oral Presentation (In-person)
Kensly Flecher, Field Epidemiology Training Program (FETP), Haiti

Background: According to the WHO, diabetes is a public health problem. Its prevalence continues to increase over the years. The number of cases has increased worldwide from 108 million in 1980 to 537 million in 2021. In Haiti, 300,000 cases were reported in 2019. The prevalence w [....] » Read More

Arun Raghavan, Speaker at Diabetes Conferences
Oral Presentation (Virtual)
Arun Raghavan, Diabetes Research Foundation, India

Transformation of healthcare delivery systems to digital platforms is on the rise. According to studies, the health informatics tools, improve management of chronic lifestyle diseases such as diabetes and heart disease. Various techniques are currently being used to remotely moni [....] » Read More

Laura Sturla, Speaker at Endocrinology Conferences
Oral Presentation (Virtual)
Laura Sturla, University of Genova, Italy

Abscisic acid (ABA) is an isoprenoid hormone with a very long evolutionary history and the only known hormone common to the vegetal and animal kingdoms, with a conserved role as a signal regulating cell responses to environmental challenge. Nanomolar ABA is also present and activ [....] » Read More

Aisling Murphy, Speaker at Endocrinology Events
Oral Presentation (Virtual)
Aisling Murphy, University of California, United States

Introduction: Gestational diabetics (GD) have both impaired insulin sensitivity and secretion, which may lead to perturbations in multiple metabolic pathways. Currently, screening paradigms for gestational diabetes mellitus (GDM) rely on demonstration of hyperglycemia after an or [....] » Read More

Sujith Rajan, Speaker at Diabetes conferences
Oral Presentation (Virtual)
Sujith Rajan, NYU Long Island School of Medicine, United States

Background: The triglyceride (TG) transfer activity of microsomal triglyceride transfer protein (MTP) is essential for lipoprotein assembly in the liver and intestine; however, its function in adipose tissue, which does not assemble lipoproteins, is unknown. Here we have elucid [....] » Read More

Alan J Stewart, Speaker at Diabetes Conferences
Keynote Presentation (Virtual)
Alan J Stewart, University of St. Andrews, United Kingdom

Diabetes is a term used to describe a group of conditions that impact upon the body’s ability to control blood glucose levels. In type-I diabetes (T1DM), the β-cells in the pancreas responsible for producing insulin are lost, typically from an attack from the immune sy [....] » Read More

Mario Allegra, Speaker at Endocrinology Conferences
Keynote Presentation (Virtual)
Mario Allegra, University of Palermo, Italy

Dysmetabolic conditions related to insulin-resistance (IR) are amongst the most common cause of death globally and their primary prevention has become a compelling goal of public health-oriented strategies. In recent years, there has been a growing interest in those natural, diet [....] » Read More

 Ashok Sharma, Speaker at Diabetes Conferences
Keynote Presentation (Virtual)
Ashok Sharma, Apollo Hospital, India

Objectives There are only three main markers for the diagnosis and management of diabetes Mellitus.  Fasting and post prandial blood sugar level gives the amount of glucose present during single point of time. On the other hand, HbA1c value reflects your average blood gluco [....] » Read More

 Jan Nemcansky, Speaker at Endocrinology Conferences
Keynote Presentation (Virtual)
Jan Nemcansky, Charles University, Czech Republic

Rising prevalence of diabetic retinopathy (DR) and diabetic macular edema represents significant burden in the society and raises challenges both in establishing effective screening and in enlargening the screening scope and mitigating the risk of DR progression.  Our goal i [....] » Read More

Wan Rosli Wan Ishak, Speaker at Endocrinology Events
Keynote Presentation (Virtual)
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia

Statement of the Problem: Presently, the prevalence of non-communicable diseases is increasingly growing with the number of diabetic people expected to increase from 171 million in 2000 to 366 million in 2030. This is the main cause of morbidity and mortality all over the world b [....] » Read More

Caroline Rheaume, Speaker at Diabetic Nutrition Conferences
Oral Presentation (Virtual)
Caroline Rheaume, Laval University, Canada

According to the World Health Organization, diabetes is the direct cause of 1.5 million deaths annually. The adoption of healthy lifestyles, such as regular and consistent physical activity, plays an important role in reducing the prevalence of diabetes and its complications. The [....] » Read More

William A Seeds, Speaker at Endocrinology Conferences
Oral Presentation (Virtual)
William A Seeds, SSRP Institute, United States

Heart disease remains the number leading cause of death year after year. The increased risk factors are certainly related to cardiovascular conditions but are also significantly attributable to metabolic disease states. There are significant advances in cardiovascular interven [....] » Read More

Brandon Lucke Wold, Speaker at Diabetes Conferences
Oral Presentation (Virtual)
Brandon Lucke Wold, University of Florida, United States

Diabetes mellitus can lead to long-standing complications in multiple arenas. An area that is often overlooked is implications for major surgery. Spinal decompression and fusions have unique challenges in the diabetic patient. In this review, we briefly highlight the pathophysiol [....] » Read More

Wenjing Hu, Speaker at Diabetes Congress
Oral Presentation (Virtual)
Wenjing Hu, Chongqing Prevention and treatment Hospital for Occupational Diseases, China

Background and aims: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting up to 13% of women of reproductive age. Although the underlying pathogenesis of PCOS has not been fully understood, there is increasing evidence that supports insulin resistance [....] » Read More

Rupesh K Gautam, Speaker at Diabetes Congress
Oral Presentation (Virtual)
Rupesh K Gautam, Department of Pharmacology, Indore Institute of Pharmacy, IIST Campus, India

Diabetes is a major public health concern that has been progressively rising worldwide. This disease is associated with a high rate of mortality, morbidity, and long-term consequences and remains a significant risk factor for cardiovascular disorders. Diabetes is a major cause of [....] » Read More

Berger Saintius, Speaker at Diabetes Conferences
Oral Presentation (Virtual)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti

Background: Diabetes is an incurable chronic disease caused by a deficiency or failure to use insulin leading to excess sugar in the blood. According to the WHO, diabetes remains a real public health problem, despite the prevention efforts implemented by the health system. In Hai [....] » Read More

Jacquet Dareus Elphana, Speaker at Endocrinology Conferences
Oral Presentation (Virtual)
Jacquet Dareus Elphana, Field Epidemiology Training Program (FETP), Haiti

Background: Diabetes is a chronic disease characterized by the presence of excess sugar in the blood called hyperglycemia. People with diabetes are twice as likely to die as healthy people. Diabetes is the leading cause of death among cardiovascular diseases. In 2021, 6.7 million [....] » Read More

Olguine Artiste, Speaker at Diabetes Conferences
Oral Presentation (Virtual)
Olguine Artiste, Field Epidemiology Training Program (FETP), Haiti

Diabetes sweet is defined by elevation chronicle of the concentration of glucose in the blood, to fasting 1.26 g/L or > 2g / L whatever collection time in presence of symptoms clinics, there are 2 types of diabetes: diabetes type1 and 2. An estimated 422 million adults were li [....] » Read More

Miguel Vazquez Moreno, Speaker at Obesity Conferences
Oral Presentation (Virtual)
Miguel Vazquez Moreno, Mexican Social Security Institute, Mexico

Background. Haptoglobin is an acute-phase inflammatory protein mainly produced by the liver. Although recent literature evidence that rs2000999 in the HP gene is associated with total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels in Mexicans, little is k [....] » Read More

Mickenson Dorsainvil, Speaker at Endocrinology Congress
Oral Presentation (Virtual)
Mickenson Dorsainvil, Field Epidemiology Training Program (FETP), Haiti

Background: Typhoid fever, with a mortality rate of 10% to 30%, is a severe disease. Its transmission is interhuman direct or indirect is a public health problem. Worldwide, the WHO estimates that there are 11 to 20 million cases resulting in 128,000 to 161,000 deaths each year. [....] » Read More

Daniela Laranja Gomes Rodrigues, Speaker at Pediatric Diabetes Conferences
Poster Presentation (Virtual)
Daniela Laranja Gomes Rodrigues, Hospital Alemão Oswaldo Cruz, Brazil

Brazil has approximately 20 million people with Diabetes Mellitus. Early identification and treatment should be a concern of public authorities, to improve glycemic control and reduce it`s deleterious impacts on the individual's health and consequent cost reduction for health [....] » Read More

Ravi Kikar Sinha, Speaker at Endocrinology Events
Poster Presentation (Virtual)
Ravi Kikar Sinha, Indian Private Researcher, India

Organic Chemists and Biochemist's attention is brought to the task of searching for enzymes and procedures to affect in vivo enzymatic ascending or descending glucose sugars  into nontoxic high or low carbon sugars  or in vivo superimposing mirror image glucose [....] » Read More